We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$777M
AUM Growth
-$10.7M
Cap. Flow
-$2.88M
Cap. Flow %
-0.37%
Top 10 Hldgs %
22.01%
Holding
267
New
2
Increased
69
Reduced
89
Closed
10

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.46M
2
AGN
Allergan plc
AGN
+$662K
3
DIS icon
Walt Disney
DIS
+$472K
4
WY icon
Weyerhaeuser
WY
+$319K
5
ATW
Atwood Oceanics
ATW
+$311K

Sector Composition

Rank Sector Weight
1 Healthcare 18.02%
2 Miscellaneous 14.73%
3 Industrials 14.1%
4 Technology 12.24%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXF icon
151
Vanguard Extended Market ETF
VXF
$30.6B
$944K 0.12%
11,293
KMR
152
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
$899K 0.12%
9,692
+40
+0.4% +$3.45K
STWD icon
153
Starwood Property Trust
STWD
$5.62B
$892K 0.11%
40,606
+866
+2% +$20.3K
DE icon
154
Deere & Co
DE
$184B
$889K 0.11%
10,845
ATW
155
DELISTED
Atwood Oceanics
ATW
$886K 0.11%
20,270
+6,490
+47% +$311K
RTN
156
DELISTED
Raytheon Company
RTN
$870K 0.11%
8,561
+1,350
+19% +$129K
IVE icon
157
iShares S&P 500 Value ETF
IVE
$49.4B
$865K 0.11%
9,600
WPP icon
158
WPP
WPP
$5.59B
$864K 0.11%
8,605
+740
+9% +$76.7K
CMCSK
159
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$851K 0.11%
15,900
ES icon
160
Eversource Energy
ES
$25.3B
$849K 0.11%
19,168
-455
-2% -$20.5K
BRK.A icon
161
Berkshire Hathaway Class A
BRK.A
$1.1T
$828K 0.11%
4
BUD icon
162
AB InBev
BUD
$157B
$805K 0.1%
7,265
SDY icon
163
State Street SPDR S&P Dividend ETF
SDY
$21.4B
$794K 0.1%
10,600
-355
-3% -$26.9K
KRFT
164
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$778K 0.1%
13,801
SWK icon
165
Stanley Black & Decker
SWK
$13.3B
$762K 0.1%
8,578
+25
+0.3% +$2.23K
NTAP icon
166
NetApp
NTAP
$37.3B
$753K 0.1%
17,525
+450
+3% +$18K
NUE icon
167
Nucor
NUE
$58.6B
$725K 0.09%
13,350
-1,275
-9% -$67.3K
GSK icon
168
GSK
GSK
$100B
$723K 0.09%
12,584
+80
+0.6% +$4.9K
AGN
169
DELISTED
Allergan plc
AGN
$713K 0.09%
+2,957
New +$662K
LLY icon
170
Eli Lilly
LLY
$1.01T
$694K 0.09%
10,700
-5
-0% -$317
HAL icon
171
Halliburton
HAL
$29.7B
$693K 0.09%
10,744
ETN icon
172
Eaton
ETN
$152B
$691K 0.09%
10,905
+591
+6% +$41.9K
IWM icon
173
iShares Russell 2000 ETF
IWM
$76.8B
$689K 0.09%
6,301
-295
-4% -$33.8K
TEL icon
174
TE Connectivity
TEL
$58.4B
$669K 0.09%
12,095
+1,600
+15% +$99.5K
STT icon
175
State Street
STT
$50.9B
$664K 0.09%
9,017
-300
-3% -$21.4K

Similar funds

Boston Family Office's Q3 2014 Portfolio in Review

As of Q3 2014, Boston Family Office held 267 positions worth $777M, down 1.4% from $788M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 4.5%. Boston Family Office opened 2 new positions and exited 10, leaving the 267-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Industrials.

  • Boston Family Office's largest Q3 2014 buy was Allergan plc: 2,957 shares worth $713K.
  • Boston Family Office added most to Verizon in Q3 2014, an estimated $1.46M increase.
  • Boston Family Office's biggest Q3 2014 reduction was AbbVie, cutting an estimated $539K.
  • Boston Family Office fully exited Meridian Bioscience Inc in Q3 2014, selling an estimated $2.13M.
  • Boston Family Office's ten largest holdings make up 22% of its $777M portfolio in Q3 2014.
  • Boston Family Office opened 2 new positions and closed 10 in Q3 2014.
  • Boston Family Office's portfolio value fell 1.4% quarter-over-quarter to $777M.

Based on Boston Family Office's 13F filing for Q3 2014, filed 31 Oct 2014.